Correo Electrónico
DNINFOA - SIA
Bibliotecas
Convocatorias
Identidad U.N.
Publicado
Encefalopatía por cefepima en paciente renal: una reacción adversa a medicamento
Cefepime encephalopathy in a kidney patient: an adverse reaction to the drug
DOI:
https://doi.org/10.15446/rcciquifa.v48n2.82715Palabras clave:
Neurotoxicidad, efectos adversos asociados a medicamentos, cefalosporinas, cefepima (es)Neurotoxicity, side effects of drugs, cephalosporins, cefepima (en)
Descargas
Referencias
K. Holloway, T. Green, Comités de farmacoterapia: guía práctica, Organización Mundial de la Salud, Ginebra, 2003, p. 155.
Commission of the European Communities, Regulation of the european parliament and of the council amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Communityprocedures for the authorisation and supervision of medicinal products for humanand veterinary use and establishing a European Medicines Agency, URL: https://ec.europa.eu/health/sites/health/files/files/pharmacos/pharmpack_12_2008/pharmacovigilance-ia-vol1_en.pdf
European Medicines Agency, 2016 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission, London, 2017, p. 1-33.
U.S. Department of Health and Human Services, Food and Drug Administration, FDA Adverse Event Reporting System (FAERS) Public Dashboard, URL: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm070093.htm
Invima, Informe programa nacional de farmacovigilancia enero-febrero 2016, Farma Seguridad, 5(1), 9-13 (2016).
Invima, Informe programa nacional de farmacovigilancia septiembre-octubre 2016, Farma Seguridad, 5(5), 7-12 (2016).
R. Solensky, D.A. Khan, L. Bernstein et al., Drug allergy: An updated practice parameter, Ann. Allergy Asthma Immunol., 105(4), 259-273 (2010).
R. Mirakian, S.C. Leech, M.T. Krishna et al., Management of allergy to penicillins and other beta-lactams, Clin. Exp. Allergy, 45(2), 300-327 (2015).
J.A. Trubiano, K.A. Cairns, J.A. Evans et al., The prevalence and impact of antimicrobial allergies and adverse drug reactions at an Australian tertiary centre, BMC Infect. Dis., 15, 572 (2015).
N.S. Shah, J.P. Ridgway, N. Pettit, J. Fahrenbach, A. Robicsek, Documenting penicillin allergy: The impact of inconsistency, PLoS One, 11(3), e0150514 (2016).
A. Romano, F. Gaeta, R.L. Valluzzi et al., IgE-mediated hypersensitivity to cephalosporins: Cross-reactivity and tolerability of alternative cephalosporins, J. Allergy Clin. Immunol., 136(3), 685-691 (2015).
C.J. Lin, S.P. Chen, S.J. Wang, J.L. Fuh, Cefepime-related encephalopathy in peritoneal dialysis patients, J. Chinese Med. Assoc., 74(2), 87-90 (2011).
S. Lam, I.H. Gomolin, Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review, Pharmacotherapy, 26, 1169-1174 (2006).
J.E. Fugate, E.A. Kalimullah, S.E. Hocker, S.L. Clark, E.F. Wijdicks, A.A. Rabinstein, Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy, Crit. Care, 17(6), R264 (2013).
S. Abanades, J. Nolla, A. Rodríguez-Campello, C. Pedro, A. Valls, M. Farré, Reversible coma secondary to cefepime neurotoxicity, Ann. Pharmacother., 38(4), 606-608 (2004).
Z. Zhang, L. Pan, H. Ni, Impact of delirium on clinical outcome in critically ill patients: A meta-analysis, Gen. Hosp. Psychiatry, 35(2), 105-111 (2013).
European Delirium Association and American Delirium Society, The DSM-5 criteria, level of arousal and delirium diagnosis: inclusiveness is safer, BMC Med., 12, 141 (2014).
H. Kim, S. Chung, Y.H. Joo, J.S. Lee, The major risk factors for delirium in a clinical setting, Neuropsychiatr. Dis. Treat., 12, 1787-1793 (2016).
K.M. Chow, A.C. Hui, C.C. Szeto, Neurotoxicity induced by beta-lactam antibiotics: From bench to bedside, Eur. J. Clin. Microbiol. Infect. Dis., 24(10), 649- 653 (2005).
K. Vellanki, V.K. Bansal, Neurologic complications of chronic kidney disease, Curr. Neurol. Neurosci. Rep., 15(8), 1-9 (2015).
M.W. Baumgaertel, M. Kraemer, P. Berlit, Chap. 24. Neurologic complications of acute and chronic renal disease. En Handbook of Clinical Neurology, Elsevier B.V., 2014, , p. 383-393.
A. Mazeraud, Q. Pascal, F. Verdonk, N. Heming, F. Chrétien, T. Sharshar, Neuroanatomy and physiology of brain dysfunction in sepsis, Clin. Chest. Med., 37(2), 333-345 (2016).
N. Chaudhry, A.K. Duggal, Sepsis associated encephalopathy, Adv. Med., (2014), 2014, 762320.
T. Dad, D.E. Weiner, Stroke and chronic kidney disease: Epidemiology, pathogenesis, and management across kidney disease stages, Semin. Nephrol., 35(4), 311-322 (2015).
H.-H. Wang, S.-Y. Hung, J.-M. Sung, K.-Y. Hung, J.-D. Wang, Risk of stroke in long-term dialysis patients compared with the general population, Am. J. Kidney Dis., 63(4), 604-611 (2014).
R.L. Sacco, S.E. Kasner, J.P. Broderick et al., An updated definition of stroke for the 21st century: A statement for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, 44(7), 2064-2089 (2013).
S.K. Sethi, V. Krishnappa, N. Nangethu, P. Nemer, L.A. Frazee, R. Raina, Antibiotic dosing in sustained low-efficiency dialysis in critically ill patients, Can. J. Kidney Health Dis., 5, 205435811879222 (2018).
Cómo citar
APA
ACM
ACS
ABNT
Chicago
Harvard
IEEE
MLA
Turabian
Vancouver
Descargar cita
Licencia
Derechos de autor 2019 Revista Colombiana de Ciencias Químico-Farmacéuticas
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
El Departamento de Farmacia de la Facultad de Ciencias de la Universidad Nacional de Colombia autoriza la fotocopia de artículos y textos para fines de uso académico o interno de las instituciones citando la fuente. Las ideas emitidas por los autores son responsabilidad expresa de estos y no de la revista.
Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons de Atribución 4.0 aprobada en Colombia. Consulte la normativa en: http://co.creativecommons.org/?page_id=13
